SOLID CANCERS
Clinical trials for SOLID CANCERS explained in plain language.
Never miss a new study
Get alerted when new SOLID CANCERS trials appear
Sign up with your email to follow new studies for SOLID CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called Anti-CEA CAR-T for people with advanced solid tumors (like colorectal or stomach cancer) that have not responded to standard therapies. The treatment uses a patient's own immune cells, modified to target a protein called CEA fou…
Matched conditions: SOLID CANCERS
Phase: PHASE1 • Sponsor: Weijia Fang, MD • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
New drug targets rare gene mutation in stubborn cancers
Disease control Recruiting nowThis study tests an experimental drug called tunlametinib in 15 adults with advanced solid tumors (not melanoma) that have a change in the NRAS gene and have stopped responding to standard treatments. The goal is to see if the drug can shrink or control the cancer. Participants w…
Matched conditions: SOLID CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated May 26, 2026 05:51 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a special radiation method called lattice radiation therapy (LRT) combined with immunotherapy for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if this combination can shrink tumors and control the disease be…
Matched conditions: SOLID CANCERS
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New combo therapy aims to tame tough cancers
Disease control Recruiting nowThis study tests a new drug called TCC1727 combined with other cancer treatments (benmelstobart, olaparib, or topotecan) in people with advanced solid tumors like lung, stomach, endometrial, or melanoma. The goal is to find the safest and most effective dose and see if the combin…
Matched conditions: SOLID CANCERS
Phase: PHASE1, PHASE2 • Sponsor: Beijing Tide Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Experimental 'Armored' cell shot targets solid cancers in tiny safety trial
Disease control Recruiting nowThis early study is testing a single injection of special immune cells (dendritic cells) that are 'armored' with antibodies to see if they are safe for people with solid tumors like pancreatic, colorectal, or stomach cancer. Only 8 adults who have already had surgery and chemothe…
Matched conditions: SOLID CANCERS
Phase: PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
AI and lab tests aim to find best cancer treatment in two weeks
Knowledge-focused Recruiting nowThis study is testing a new approach called xDRIVE that combines lab tests on tumor samples with artificial intelligence to suggest personalized cancer treatments. It involves 210 Florida patients with cancers that have come back or not responded to standard therapy, including ch…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 06:33 UTC
-
770 cancer patients help unlock secrets of immunotherapy
Knowledge-focused Recruiting nowThis study aims to find biological markers in blood and tumor samples that predict how well immunotherapy works and what side effects may occur. It will enroll 770 adults with advanced solid cancers like lung, head and neck, melanoma, or bladder cancer who are receiving immune ch…
Matched conditions: SOLID CANCERS
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC